Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.1.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.22ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.22ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.22EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.22EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
BA.2.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BA.2.75ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.75EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.75EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.75ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5 (Omicron)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5 (Omicron)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5 (Omicron)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5 (Omicron)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5 (Omicron)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5 (Omicron)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5 (Omicron)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.6.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.6.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.6.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used